EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anticoagulation for Left Ventricular Thrombosis Post-Myocardial Infarction – Current Recommendations and Future Perspectives

Mihai Ștefan Cristian Haba, Andreea-Simona Ungurenașu, Elena Cosmina Ciobanu, Florin Mitu, Radu Stefan Miftode, Ovidiu Mitu

Romanian Journal of Cardiology · 2022

DOI: 10.2478/rjc-2022-0005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Romanian Journal of Cardiology, 2022. Verfasst von Mihai Ștefan Cristian Haba und 5 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Left ventricular thrombosis (LVT) is one of the most severe complications of acute myocardial infarction (AMI). LVT is commonly associated with an increased risk of cerebral or systemic embolization, which furthermore increases the morbidity and mortality of these patients. Management of LVT implies the administration of anticoagulants to achieve thrombus resolution and reduce the embolic risk. However, in the setting of an AMI, anticoagulants are added to already existing antiplatelet therapy, which increases the bleeding risk for this category of patients. Vitamin K antagonist (VKA) represents the main guideline recommendation for anticoagulation, but its multiple interactions are associated with an increased number of patients who are outside the therapeutic range and low compliance. Early studies that evaluate direct oral anticoagulants (DOAC) as an alternative for VKA show promising results, with reduced strokes and bleeding rates and faster thrombus resolution. Thus, in the near future, DOAC may represent a therapeutic option for treating LVT, but larger studies are needed to validate this approach.

Zitieren

APA

Haba, M. Ș. C., Ungurenașu, A., Ciobanu, E. C., Mitu, F., Miftode, R. S., & Mitu, O. (2022). Anticoagulation for Left Ventricular Thrombosis Post-Myocardial Infarction – Current Recommendations and Future Perspectives. Romanian Journal of Cardiology. https://doi.org/10.2478/rjc-2022-0005

Vancouver

Haba MȘC, Ungurenașu A, Ciobanu EC, Mitu F, Miftode RS, Mitu O. Anticoagulation for Left Ventricular Thrombosis Post-Myocardial Infarction – Current Recommendations and Future Perspectives. Romanian Journal of Cardiology. 2022. doi:10.2478/rjc-2022-0005

BibTeX
@article{Haba2022,
  author = {Haba, Mihai Ștefan Cristian and Ungurenașu, Andreea-Simona and Ciobanu, Elena Cosmina and Mitu, Florin and Miftode, Radu Stefan and Mitu, Ovidiu},
  title = {Anticoagulation for Left Ventricular Thrombosis Post-Myocardial Infarction – Current Recommendations and Future Perspectives},
  journal = {Romanian Journal of Cardiology},
  year = {2022},
  doi = {10.2478/rjc-2022-0005}
}
Kostenlos starten →